Use of a Schelin catheter for transurethral intraprostatic anesthesia (TUIA) prior to iTIND procedure

Endorsing the principles of minimal invasiveness in benign-prostatic hyperplasia (BPH) surgery, we conducted the first evaluation of transurethral intraprostatic anesthesia (TUIA) using Schelin catheter® (SC) prior to iTIND positioning. Of 23 patients enrolled, 11 (48%) received TUIA via SC whereas...

Full description

Saved in:
Bibliographic Details
Published in:Prostate cancer and prostatic diseases 2024-09
Main Authors: Secco, Silvia, Olivero, Alberto, Longoni, Mattia, Dell'Oglio, Paolo, Tappero, Stefano, Dibilio, Edoardo, Saccucci, Tommaso, Siena, Giampaolo, Bocciardi, Aldo Massimo, Galfano, Antonio, Cindolo, Luca
Format: Article
Language:English
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Endorsing the principles of minimal invasiveness in benign-prostatic hyperplasia (BPH) surgery, we conducted the first evaluation of transurethral intraprostatic anesthesia (TUIA) using Schelin catheter® (SC) prior to iTIND positioning. Of 23 patients enrolled, 11 (48%) received TUIA via SC whereas the remaining underwent standard anesthesia protocol. Pain was assessed using visual analogue scale (VAS). No differences between cohorts were observed for pain during the device implantation and removal. Conversely, significantly lower median VAS scores were reported at 24- (1.0 vs. 3.0) and 48- (1.0 vs. 2.5) hour follow-up favoring TUIA. SC TUIA offers effective pain control during iTIND procedures, supporting its use in outpatient settings.
ISSN:1365-7852
1476-5608
1476-5608
DOI:10.1038/s41391-024-00892-2